CSIMarket
 


Innoviva inc   (INVA)
Other Ticker:  
 
 

INVA's Income from Cont. Operations Growth by Quarter and Year

Innoviva Inc 's Income from Cont. Operations results by quarter and year




INVA Income from Cont. Operations (in millions $) FY 2020 FY 2019 FY 2018 FY 2017
IV Quarter December - 57.86 269.22 58.51
III Quarter September - 47.05 50.17 23.77
II Quarter June 98.23 46.06 56.62 35.15
I Quarter March 78.95 40.02 30.33 16.85
FY   177.18 190.99 406.34 134.28



INVA Income from Cont. Operations second quarter 2020 Y/Y Growth Comment
Innoviva inc achieved in the second quarter, above Company average Income from Cont. Operations surge of 113.25% year on year, to $ 98.23 millions.

According to the results reported in the second quarter, Innoviva Inc achieved the best Income from Cont. Operations growth in Major Pharmaceutical Preparations industry. While Innoviva Inc ' s Income from Cont. Operations doubling of 113.25% ranks overall at the positon no. 48 in the second quarter.




INVA Income from Cont. Operations ( Y/Y Growth %) 2020
2019 2018 2017
IV Quarter December - -78.51 % 360.13 % 129.72 %
III Quarter September - -6.22 % 111.06 % 58.15 %
II Quarter June 113.25 % -18.65 % 61.08 % 140.75 %
I Quarter March 97.28 % 31.95 % 80 % 279.5 %
FY   - -53 % 202.61 % 125.53 %

Financial Statements
Innoviva Inc 's second quarter 2020 Income from Cont. Operations $ 98.23 millions INVA's Income Statement
Innoviva Inc 's second quarter 2019 Income from Cont. Operations $ 46.06 millions Quarterly INVA's Income Statement
New: More INVA's historic Income from Cont. Operations Growth >>


INVA Income from Cont. Operations (Quarter on Quarter Growth %)

2020
2019 2018 2017
IV Quarter December - 22.98 % 436.62 % 146.15 %
III Quarter September - 2.15 % -11.39 % -32.38 %
II Quarter June 24.41 % 15.09 % 86.68 % 108.61 %
I Quarter March 36.45 % -85.13 % -48.16 % -33.84 %
FY (Year on Year)   - -53 % 202.61 % 125.53 %




Income from Cont. Operations second quarter 2020 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #1
Healthcare Sector #5
Overall #48

Income from Cont. Operations Y/Y Growth Statistics
High Average Low
107.71 % 24.3 % -52.53 %
(Dec 31 2018)   (Dec 31 2019)
Income from Cont. Operations second quarter 2020 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #1
Healthcare Sector #5
Overall #48
Income from Cont. Operations Y/Y Growth Statistics
High Average Low
107.71 % 24.3 % -52.53 %
(Dec 31 2018)   (Dec 31 2019)

Income from Cont. Operations by Quarter for the Fiscal Years 2017, 2018, 2019, 2020

Innoviva Inc 's Q/Q Income from Cont. Operations Growth


Income from Cont. Operations Q/Q Growth Statistics
High Average Low
436.64 % 54.05 % -85.13 %
(Dec 31 2018)  


INVA's II. Quarter Q/Q Income from Cont. Operations Comment
Innoviva inc achieved in the II. Quarter 2020 below company average Income from Cont. Operations jump of 24.41% quarter on quarter, to $ 98.23 millions.

Even if the II. Quarter 2020 results were beneath the average , this has been yet good sign, as the II. Quarter expension, eclipses the 15.09% rise in the same quarter a year ago

Within Major Pharmaceutical Preparations industry Innoviva inc achieved highest sequential Income from Cont. Operations growth. While Innoviva Inc 's Income from Cont. Operations growth quarter on quarter, overall rank is 89.


Income from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #1
Healthcare Sector #7
Overall #89
Income from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #1
Healthcare Sector #7
Overall #89
Income from Cont. Operations Q/Q Growth Statistics
High Average Low
436.64 % 54.05 % -85.13 %
(Dec 31 2018)  


INVA's II. Quarter Q/Q Income from Cont. Operations Comment
Innoviva inc achieved in the II. Quarter 2020 below company average Income from Cont. Operations jump of 24.41% quarter on quarter, to $ 98.23 millions.

II. Quarter 2020 Innoviva Inc 's results seem to be contradictory, even if lower than the regular rise of 54.05 %, yet it presents real improvement compare to the 15.09% in the II. Quarter 2019 Rachel Miller, an industry contributor from Philadelphia mentioned.

Within Major Pharmaceutical Preparations industry Innoviva inc achieved highest sequential Income from Cont. Operations growth. While Innoviva Inc 's Income from Cont. Operations growth quarter on quarter, overall rank is 89.


Innoviva Inc 's 12 Months Income from Cont. Operations Growth Year on Year


Income from Cont. Operations TTM Growth

12 Months Ending
(Jun 30 2020)
12 Months Ending
(Mar 31 2020)
12 Months Ending
(Dec 31 2019)
12 Months Ending
(Sep 30 2019)
12 Months Ending
(Jun 30 2019)
Cumulative Income from Cont. Operations 12 Months Ending $ 282.09 $ 229.93 $ 190.99 $ 402.35 $ 405.46
Y / Y Income from Cont. Operations Growth (TTM) -30.43 % -44.73 % -53 % 105.67 % 139.6 %
Year on Year Income from Cont. Operations Growth Overall Ranking # 259 # 520 # 589 # 247 # 0
Seqeuential Income from Cont. Operations Change (TTM) 22.69 % 20.38 % -52.53 % -0.77 % -2.54 %
Seq. Income from Cont. Operations Growth (TTM) Overall Ranking # 48 # 71 # 669 # 1197 # 0




Cumulative Income from Cont. Operations growth Comment
Innoviva Inc showed decline, but improvement compare to trailing twelve month Income from Cont. Operations decrease in Mar 31 2020. If the fiscal year would end in Jun 30 2020, Innoviva Inc 's annual Income from Cont. Operations decline would be -30.43% year on year to $282 millions.

Among companies within the Healthcare sector 18 other companies have achieved higher trailing twelve month Income from Cont. Operations growth. While Total ranking has impoved so far to 259, from total ranking in previous quarter at 520.

Income from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
107.71 %
24.3 %
-52.53 %
 

Income from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 1
Healthcare Sector # 19
Overall # 259

Income from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
393.33 %
119.41 %
-53 %
 


Income from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry # 1
Sector # 5
S&P 500 # 48
Cumulative Income from Cont. Operations growth Comment
Innoviva Inc showed decline, but improvement compare to trailing twelve month Income from Cont. Operations decrease in Mar 31 2020. If the fiscal year would end in Jun 30 2020, Innoviva Inc 's annual Income from Cont. Operations drop would be -30.43% year on year to $282 millions.

Among companies within the Healthcare sector 18 other companies have achieved higher trailing twelve month Income from Cont. Operations growth. While Total ranking has impoved so far to 259, from total ranking in previous quarter at 520.

Income from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
107.71 %
24.3 %
-52.53 %
 


Income from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 1
Healthcare Sector # 19
Overall # 259

Income from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
393.33 %
119.41 %
-53 %
 


Income from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry # 1
Sector # 5
S&P 500 # 48




Other Income from Cont. Operations Growth
Major Pharmaceutical Preparations Industry Income from Cont. Operations Growth Trends and Statistics
Healthcare Sector Income from Cont. Operations Growth Statistics
Income from Cont. Operations Growth Trends for overall market
INVA's Income from Cont. Operations Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Income from Cont. Operations Growth
Lowest Ranking Income from Cont. Operations Growth
Income from Cont. Operations Growth for INVA's Competitors
Income from Cont. Operations Growth for Innoviva Inc 's Suppliers
Income from Cont. Operations Growth for INVA's Customers

You may also want to know
INVA's Annual Growth Rates INVA's Profitability Ratios INVA's Asset Turnover Ratio INVA's Dividend Growth
INVA's Roe INVA's Valuation Ratios INVA's Financial Strength Ratios INVA's Dividend Payout Ratio
INVA's Roa INVA's Inventory Turnover Ratio INVA's Growth Rates INVA's Dividend Comparisons



Companies with similar Income from Cont. Operations drop for the quarter ending Jun 30 2020 within Healthcare SectorY/Y Change %Income from Cont. Operations for the quarter ending Jun 30 2020
Hill rom Holdings Inc   188.04 %$ 188.037 millions
Incyte Corp  175.64 %$ 175.639 millions
Coherus Biosciences inc   150.48 %$ 150.482 millions
Nature s Sunshine Products inc   133.28 %$ 133.283 millions
Innoviva inc   113.25 %$ 113.250 millions
National Healthcare Corp  108.46 %$ 108.464 millions
Ironwood Pharmaceuticals inc   105.19 %$ 105.194 millions
Repligen Corp  95.94 %$ 95.936 millions
Lhc Group Inc  93.07 %$ 93.069 millions
Surmodics Inc   67.74 %$ 67.735 millions
Luna Innovations Inc  62.92 %$ 62.920 millions
Chemed Corporation  61.84 %$ 61.842 millions
Bio rad Laboratories Inc   61.39 %$ 61.392 millions
Tivity Health Inc   57.20 %$ 57.198 millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

AERI's Profile

Stock Price

AERI's Financials

Business Description

Fundamentals

Charts & Quotes

AERI's News

Suppliers

AERI's Competitors

Customers & Markets

Economic Indicators

AERI's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2020 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071